POR vs REGN · P/E 22, rev $1.69B vs P/E 14, rev $4.29B
Portland General Electric Co (POR) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Portland General Electric Co (POR) is a utilities - regulated electric company listed on NYSE.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported POR revenue for 2026-06-30 was $1.69B. Net income was $113.0M. Revenue was up 92.6% from 2026-03-31 to 2026-06-30. POR currently screens at market cap $5.76B and trailing P/E 22.2.
Latest reported REGN revenue for 2026-06-30 was $4.29B. Net income was $1.30B. Revenue was up 19.0% from 2026-03-31 to 2026-06-30. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
POR currently screens at market cap $5.76B and trailing P/E 22.2. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the POR and REGN stock pages for the full models.
Not investment advice.